Section 1 Short title This Act may be cited as the “Adding Ebola to the FDA Priority Review Voucher Program Act”. ⋯
Sec. 2 Priority review to encourage treatments for tropical diseases Section 524 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended— ⋯ (1) in subsection (a)(3)— ⋯ (A) by redesignating subparagraph (Q) as subparagraph (R); ⋯ (B) by inserting after subparagraph (P) the following: ⋯ “(Q) Filoviruses.” (C) in subparagraph (R), as so redesignated, by striking “regulation by” and inserting “order of”; and ⋯ (2) in subsection (b)— ⋯ (A) in paragraph (2), by adding “There is no limit on the number of times a priority review voucher may be transferred before such voucher is used.” after the period at the end; and ⋯ (B) in paragraph (4), by striking “365 days” and inserting “90 days”. ⋯